Kalshi has mostly done things by the books, cozying up to the federal government in search of regulation and unmitigated approval. Meanwhile, Polymarket has seemed to make its own rules, letting users ...

But if the court ruled for the CFTC, Kalshi would have to accept that every time it wanted to do something its regulator didn’t like, it would be stopped. A loss might not have killed the company, but ...

Three health-technology names are drawing fresh analyst attention as strategic partnerships and business pivots reframe their risk-reward profiles.